Showing results (321-330 of 341) with videos related to
Sort By:
Pageof 35
British Journal of Cancer|September 17, 2009
Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitorsM Hauglid Flågeng, L L Haugan Moi, J M Dixon, et al.Oncology Reports|May 21, 2011
Growth-control of human ovarian-carcinoma cells by insulin-like growth-factorsJ M Bartlett, G J Rabiasz, W N Scott, et al.Clinical Oncology|March 1, 1984
Protein concentrations in fluid from gross cystic disease of the breastP L Yap, W R Miller, M M Roberts, et al.European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Transforming growth factor-beta isoform expression in human ovarian tumoursJ M Bartlett, S P Langdon, W N Scott, et al.British Journal of Cancer|August 1, 1992
Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cellsG J Rabiasz, S P Langdon, J M Bartlett, et al.British Journal of Cancer|March 1, 2002
Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsiesP T K Saunders, M R Millar, K Williams, et al.British Journal of Cancer|August 1, 1990
Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell linesS P Langdon, M M Hawkes, S S Lawrie, et al.Journal of the Royal Society of Medicine|August 1, 1980
Preoperative assessment and staging of breast cancer: preliminary communicationA P Forrest, R B Black, V Humeniuk, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
The primary use of endocrine therapiesA Howell, E Anderson, R Blamey, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogenS P Langdon, H Gabra, J M Bartlett, et al.Pageof 35